Snivri Bio Cares Private Limited
Founded in 2019 and headquartered in Delhi, India.
2019 | Delhi (India) | Active
Snivri Bio Cares Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.80 Cr
- Revenue Growth 224.06%
- Profit Growth 35.94%
- Ebitda 152.06%
- Net Worth 26.01%
- Total Assets -6.83%
About Snivri Bio Cares
Snivri Bio Cares Private Limited (SBCPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 January 2019 (Six years and one month 25 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.80 Cr.
Mohit Goel and Varun Goel serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24234DL2019PTC343678
- Company No.
343678
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Chemicals
Pharmaceuticals
Who are the key members and board of directors at Snivri Bio Cares?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohit Goel  | Director | 01-Jan-2019 | Current |
| Varun Goel | Director | 01-Jan-2019 | Current |
Financial Performance of Snivri Bio Cares.
Snivri Bio Cares Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 224.06% increase. The company also saw a substantial improvement in profitability, with a 35.94% increase in profit. The company's net worth Soared by an impressive increase of 26.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Snivri Bio Cares?
Unlock access to Snivri Bio Cares's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹18.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 1.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2020 | Others | ₹1.80 Cr | Open |
How Many Employees Work at Snivri Bio Cares?
Unlock and access historical data on people associated with Snivri Bio Cares, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Snivri Bio Cares, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Snivri Bio Cares's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.